SHR-2031
N/A
Report date: 2024/07/31 15:02:30
Base Information
Drug NameSHR-2031
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesJiangsu Hengrui Medicine Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesJiangsu Hengrui Medicine Co Ltd
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A